A trend towards a reduced risk of recurrent ACS has been observed, although the difference did not reach statistical significance.
← all excerpts
Early in-hospital use of SGLT2i in heart failure patients with ischemic etiology.
1
—
—
A trend towards a reduced risk of recurrent ACS has been observed, although the difference did not reach statistical significance.